Vaccines

To mark the end of 2023, we compiled a list of this year’s Pharmacology Consult columns, in which our contributing PharmDs dig deep into the newest research to report on emerging therapies and vaccines for infectious diseases.

A recombinant influenza vaccine offered additional protection against PCR-confirmed influenza and community-acquired pneumonia hospitalization among adults aged 50 to 64 years compared with a standard-dose vaccine, study results showed.

It's that time of year again, everyone rolling up their sleeves to get a flu shot. This episode dives into the history of the struggles pinning down the causative agent of flu and the journey to the vaccine!

Globally, cases of malaria in 2022 surpassed the level recorded the year before the start of the COVID-19 pandemic, WHO reported this week.

When given together, Pfizer’s respiratory syncytial virus vaccine and the seasonal influenza vaccine generated robust immune responses and were well tolerated among older adults when coadministered, data from a recent study showed.

Respiratory syncytial virus incidence rates among pregnant people are lower than those seen in older adults and young children, although researchers say rates are still significant and warrant consideration in vaccine policy decisions.

Healio spoke with several experts to get their feedback on the first two malaria vaccines ever recommended for use and how they will impact the fight against the disease, which threatens half the global population.

Scientists have successfully developed the first vaccines against malaria and respiratory syncytial virus, but other vaccine targets remain.

In the last few years, major strides have been made in the fight to control malaria, including the first two malaria vaccines ever recommended for use.

New American Academy of Family Physicians President Steven P. Furr, MD, FAAFP, is focused on increasing pay for family physicians to account for the comprehensive care they provide and draw more students to the field.